scholarly journals COVID-19 in Saudi Arabia: the national health response

2021 ◽  
Author(s):  
Anas A. Khan ◽  
Yousef M. Alsofayan ◽  
Ahmed A. Alahmari ◽  
Jalal M. Alowais ◽  
Abdullah R. Algwizani ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
World Health ◽  
Private Institutions ◽  
Governance System ◽  
Public And Private ◽  
Proper Actions ◽  
Social Events ◽  
First Case ◽  
Self Sufficiency ◽  
Health Response

Background: With the spread of coronavirus disease 2019 (COVID-19), most countries rushed to take early measures to control this disease. Aims: This paper describes and evaluates the Saudi Arabian strategic preparedness and response plan on COVID-19 up to 31 December 2020. Methods: Saudi Arabia adopted the World Health Organization’s guidelines on response to COVID-19, which are based on nine pillars of public health preparedness and response. The measures Saudi Arabia took are assessed against these pillars. Results: In response to COVID-19, Saudi Arabia prepared public and private institutions to deal with the pandemic. Saudi authorities established a governance system comprised of responsible committees to continuously monitor national and international updates, trace contacts, screen the population, raise awareness and take proper actions to contain the spread of this disease. After the announcement of the first case in Saudi Arabia, all schools, social events, sports activities, domestic travel and international flights were suspended. Restrictions on social movement, social and religious gatherings, travel and businesses were imposed ahead of the first 100 confirmed COVID-19 cases. The Hajj pilgrimage for 2020 was scaled down to limit participants and no cases of COVID-19 were detected among pilgrims. The country maintained all basic health services and immunization programmes and supported all proposals for COVID-19 drugs and vaccines. The country is working to develop its capacity to produce these products and achieve self-sufficiency. Conclusion: Saudi Arabia took extreme measures to respond to COVID-19 which contributed to limiting the spread and effect of the disease.

scholarly journals Estimating COVID-19 cases in Makkah region of Saudi Arabia: Space-time ARIMA modeling

PLoS ONE ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. e0250149
Author(s):  
Fuad A. Awwad ◽  
Moataz A. Mohamoud ◽  
Mohamed R. Abonazel
Keyword(s):  
Saudi Arabia ◽  
Moving Average ◽  
Arima Model ◽  
Daily Basis ◽  
World Health ◽  
Arima Models ◽  
Autoregressive Integrated Moving Average ◽  
First Case ◽  
Novel Coronavirus ◽  
The Impact

The novel coronavirus COVID-19 is spreading across the globe. By 30 Sep 2020, the World Health Organization (WHO) announced that the number of cases worldwide had reached 34 million with more than one million deaths. The Kingdom of Saudi Arabia (KSA) registered the first case of COVID-19 on 2 Mar 2020. Since then, the number of infections has been increasing gradually on a daily basis. On 20 Sep 2020, the KSA reported 334,605 cases, with 319,154 recoveries and 4,768 deaths. The KSA has taken several measures to control the spread of COVID-19, especially during the Umrah and Hajj events of 1441, including stopping Umrah and performing this year’s Hajj in reduced numbers from within the Kingdom, and imposing a curfew on the cities of the Kingdom from 23 Mar to 28 May 2020. In this article, two statistical models were used to measure the impact of the curfew on the spread of COVID-19 in KSA. The two models are Autoregressive Integrated Moving Average (ARIMA) model and Spatial Time-Autoregressive Integrated Moving Average (STARIMA) model. We used the data obtained from 31 May to 11 October 2020 to assess the model of STARIMA for the COVID-19 confirmation cases in (Makkah, Jeddah, and Taif) in KSA. The results show that STARIMA models are more reliable in forecasting future epidemics of COVID-19 than ARIMA models. We demonstrated the preference of STARIMA models over ARIMA models during the period in which the curfew was lifted.

scholarly journals Atypical presentation of Middle East respiratory syndrome coronavirus in a Lebanese patient returning from Saudi Arabia

2018 ◽  
Vol 12 (09) ◽  
pp. 808-811 ◽  
Author(s):  
Saeed El Zein ◽  
Jinane Khraibani ◽  
Nada Zahreddine ◽  
Rami Mahfouz ◽  
Nada Ghosn ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Middle East ◽  
Medical Center ◽  
Middle East Respiratory Syndrome ◽  
World Health ◽  
American University ◽  
American University Of Beirut ◽  
Persistent Symptoms ◽  
First Case ◽  
Health Organization

Around 2090 confirmed cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from 27 countries have been reported to the World Health Organization (WHO) between September 2012 and October 2017, the majority of whom occurring in countries in the Arabian Peninsula, mainly in Saudi Arabia. MERS- CoV can have atypical and misleading presentations resulting in delays in diagnosis and is associated with a high mortality rate especially in elderly patients with multiple comorbidities. Herein, we present the first case of confirmed MERS-CoV infection diagnosed at the American University of Beirut Medical Center (AUBMC) - Lebanon in June 2017 presenting without any respiratory symptoms. This is the second confirmed case of MERS-CoV infection in Lebanon since 2014. The first case presented with a febrile respiratory infection with persistent symptoms despite antibiotic treatment.

scholarly journals Assessment of handwritten prescriptions from Saudi Arabia according to international guidelines

2020 ◽  
Vol 8 ◽  
pp. 205031212097715
Author(s):  
Souhib Mohammed Youssef ◽  
Mohamed Saddik Zaghloul ◽  
Mohammed Fayez Ahmed ◽  
Abdul Nasser Ahmed Barmo ◽  
Asghar Mehdi Muhammed Mehdi ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Health Care Facilities ◽  
World Health ◽  
Private Health Care ◽  
Missing Information ◽  
Public And Private ◽  
International Guidelines ◽  
Contact Information ◽  
Care Facilities ◽  
Health Organization

Objective: Prescription dispensing services are not digitalized in the majority of governmental hospitals and private clinics in Saudi Arabia, which makes them prone to error. We aimed to evaluate handwritten prescriptions in a region in Saudi Arabia for consistency and accuracy according to international guidelines. Methods: A sample of handwritten prescriptions (dated 2016 or 2017) from selected pharmacies in the Al-Qassim region (n = 556) were evaluated for missing information on items related to prescriber, patient, and medication according to the World Health Organization and Food and Drug Administration guidelines. Results: We found that the prescriber’s name and contact information were missing in two-thirds of the prescriptions (66%). Patients’ addresses were always missing (100%). No prescription contained medication warnings; a majority lacked information on mode of administration (68%) and methods to avoid refilling (66%). Conclusion: Saudi Arabia should take a multipronged approach, including digitalization of prescription dispensing services, in both public and private health care facilities in order to reduce prescription errors.

Hospitalized Psychiatric Morbidity in the Republic of Ireland

1968 ◽  
Vol 114 (506) ◽  
pp. 11-14 ◽  
Author(s):  
Dermot Walsh
Keyword(s):  
Psychiatric Morbidity ◽  
World Health ◽  
Private Institutions ◽  
Public And Private ◽  
Republic Of Ireland ◽  
Number Of Patients ◽  
The World ◽  
The Republic ◽  
Health Organization ◽  
First Time

There seems little doubt from available statistics that the Republic of Ireland has the highest rate of hospitalized psychiatric morbidity in the world. There are no complete international figures available for this statistic but the World Health Organization published for the first time in 1961 returns for numbers of patients treated in hospital in 119 different countries (W.H.O. 1961). In many cases the returns were incomplete or unsatisfactory in one or more particulars. The ideal was to establish for each country the total number of patients treated during each one of the five years 1955–1959. The number treated was defined as “the patients present at the beginning of the year in the various public and private institutions specializing in psychiatry and in other institutions (general hospitals, etc.) plus admissions and readmissions during the year”. Unfortunately this ideal was achieved for only a minority of the 119 countries. The difficulties encountered in compiling the figures are set out in the publication itself.

scholarly journals Infection Spread, Recovery, and Fatality from Coronavirus in Different Provinces of Saudi Arabia

Healthcare ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 931
Author(s):  
Mohammed Muberek Alharbi ◽  
Syed Imam Rabbani ◽  
Syed Mohammed Basheeruddin Asdaq ◽  
Abdulhakeem S. Alamri ◽  
Walaa F. Alsanie ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Case Fatality ◽  
World Health ◽  
Kingdom Of Saudi Arabia ◽  
First Case ◽  
Northern Border ◽  
Propagation Pattern ◽  
Novel Coronavirus ◽  
Health Organization ◽  
June July

The World Health Organization (WHO) announced COVID-19, a novel coronavirus outbreak, as a pandemic in 2020. In the month of February 2020, the disease began to spread through the Middle East. The first case of COVID-19 in the Kingdom of Saudi Arabia was identified in March 2020, and it is now one of the region’s most affected countries. Analyzing the disease’s propagation pattern may aid in the development of pandemic-fighting strategies. This study aims to analyze the trend of COVID-19’s spread, its recovery, and mortality in the Kingdom of Saudi Arabia (KSA). Two to three major cities from the 13 provinces of the country were chosen, and the rate of infection recovery was recorded from the first month until the number of confirmed cases showed a decline. The data published on the official Ministry of Health website were recorded on an Excel sheet, graphically represented as figures to indicate the pattern of spread. According to the study’s findings, COVID-19 positive cases were discovered in the majority of provinces as early as March 2020. The province of Makkah had the largest number of COVID-19 positive cases (30.7%), followed by Riyadh (23%). The province of Al Jowf had the lowest number of COVID-19 cases (0.3%). Tabuk province had the highest rate of recovery (97.8%), followed by the Northern Border Province (96.7%). Makkah province had the highest mortality rate (2.6%), followed by Al Jawf province (2.4%). The peak case–fatality ratio was recorded in August and September. The highest number of tests to detect the COVID-19 was performed in the month of July, and the highest percentage of positive cases was detected in June (19.55%). All the provinces from the month of September 2020 showed a progressive decline in the number of confirmed COVID-19 cases. According to this study, COVID-19 infection was found in the majority of Saudi Arabian provinces in March 2020, with a peak in June–July 2020. Considering the climatic and demographic characteristics of the region, specific modalities need to be adopted in collaboration with international guidelines to defeat the COVID-19 pandemic.

Policy Review: Dubai Health Authority’s COVID-19 Rapid Response

2020 ◽  
Vol 5 (Special) ◽  
Keyword(s):  
United Arab Emirates ◽  
Well Being ◽  
Healthcare Services ◽  
Rapid Response ◽  
Policy Implications ◽  
World Health ◽  
Healthcare Sector ◽  
Services Delivery ◽  
First Case ◽  
The World

Dubai Health Authority (DHA) is the entity regulating the healthcare sector in the Emirate of Dubai, ensuring high quality and safe healthcare services delivery to the population. The World Health Organization (WHO) declared COVID-19 a pandemic on the 11th of March 2020, indicating to the world that further infection spread is very likely, and alerting countries that they should be ready for possible widespread community transmission. The first case of COVID-19 in the United Arab Emirates was confirmed on 29th of January 2020; since then, the number of cases has continued to grow exponentially. As of 8th of July 2020 (end of the day), 53,045 cases of coronavirus have been confirmed with a death toll of 327 cases. The UAE has conducted over 3,720,000 COVID-19 tests among UAE citizens and residents over the past four months, in line with the government’s plans to strengthen virus screening to contain the spread of COVID-19. There were vital UAE policies, laws, regulations, and decrees that have been announced for immediate implementation to limit the spread of COVID- 19, to prevent panic and to ensure the overall food, nutrition, and well-being are provided. The UAE is amongst the World’s Top 10 for COVID-19 Treatment Efficiency and in the World’s Top 20 for the implementation of COVID-19 Safety measures. The UAE’s mission is to work towards resuming life after COVID-19 and enter into the recovery phases. This policy research paper will discuss the Dubai Health Authority’s rapid response initiatives towards combating the control and spread of COVID-19 and future policy implications and recommendations. The underlying factors and policy options will be discussed in terms of governance, finance, and delivery.

Harel-Yoon syndrome: the first case report from Saudi Arabia

2020 ◽  
pp. 22-27 ◽  
Author(s):  
Alaa AlAyed ◽  
Manar Samman ◽  
Abdul Peer-Zada ◽  
Mohammed Almannai
Keyword(s):  
Saudi Arabia ◽  
Case Report ◽  
First Case

Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status

2020 ◽  
Vol 18 ◽  
Author(s):  
Rina Das ◽  
Dinesh Kumar Mehta ◽  
Meenakshi Dhanawat
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Clinical Symptoms ◽  
Virus Disease ◽  
Relevant Literature ◽  
World Health ◽  
Current Status ◽  
Future Research ◽  
Treatment And Prevention ◽  
First Case ◽  
Novel Coronavirus

Abstract:: A novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared and expanded globally by the end of year in 2019 from Wuhan, China, causing severe acute respiratory syndrome. During its initial stage, the disease was called the novel coronavirus (2019-nCoV). It was named COVID-19 by the World Health Organization (WHO) on 11 February 2020. The WHO declared worldwide the SARS-CoV-2 virus a pandemic on March 2020. On 30 January 2020 the first case of Corona Virus Disease 2019 (COVID-19) was reported in India. Now in current situation the virus is floating in almost every part of the province and rest of the globe. -: On the basis of novel published evidences, we efficiently summarized the reported work with reference to COVID-19 epidemiology, pathogen, clinical symptoms, treatment and prevention. Using several worldwide electronic scientific databases such as Pubmed, Medline, Embase, Science direct, Scopus, etc were utilized for extensive investigation of relevant literature. -: This review is written in the hope of encouraging the people successfully with the key learning points from the underway efforts to perceive and manage SARS-CoV-2, suggesting sailent points for expanding future research.

Impact of hydroxychloroquin/azithromycin protocol on COVID-19 case-fatality rate reduction in Algeria. (Preprint)

2020 ◽  
Author(s):  
Ahmed Youssef Kada
Keyword(s):  
Case Fatality Rate ◽  
Doubling Time ◽  
Case Fatality ◽  
World Health ◽  
Fatality Rate ◽  
Therapeutic Protocol ◽  
First Case ◽  
The World ◽  
The Impact ◽  
At Home

BACKGROUND Covid-19 is an emerging infectious disease like viral zoonosis caused by new coronavirus SARS CoV 2. On December 31, 2019, Wuhan Municipal Health Commission in Hubei province (China) reported cases of pneumonia, the origin of which is a new coronavirus. Rapidly extendable around the world, the World Health Organization (WHO) declares it pandemic on March 11, 2020. This pandemic reaches Algeria on February 25, 2020, date on which the Algerian minister of health, announced the first case of Covid-19, a foreign citizen. From March 1, a cluster is formed in Blida and becomes the epicentre of the coronavirus epidemic in Algeria, its total quarantine is established on March 24, 2020, it will be smoothly alleviated on April 24. A therapeutic protocol based on hydroxychloroquine and azithromycin was put in place on March 23, for complicated cases, it was extended to all the cases confirmed on April 06. OBJECTIVE This study aimed to demonstrate the effectiveness of hydroxychloroquin/azithromycin protocol in Algeria, in particular after its extension to all patients diagnosed COVID-19 positive on RT-PCR test. We were able to illustrate this fact graphically, but not to prove it statistically because the design of our study, indeed in the 7 days which followed generalization of therapeutic protocol, case fatality rate decrease and doubling time increase, thus confirming the impact of wide and early prescription of hydroxychloroquin/azithromycin protocol. METHODS We have analyzed the data collected from press releases and follow-ups published daily by the Ministry of Health, we have studied the possible correlations of these data with certain events or decisions having a possible impact on their development, such as confinement at home and its reduction, the prescription of hydroxychloroquine/azithromycin combination for serious patients and its extension to all positive COVID subjects. Results are presented in graphics, the data collection was closed on 31/05/2020. RESULTS Covid-19 pandemic spreads from February 25, 2020, when a foreign citizen is tested positive, on March 1 a cluster is formed in the city of Blida where sixteen members of the same family are infected during a wedding party. Wilaya of Blida becomes the epicentre of coronavirus epidemic in Algeria and lockdown measures taken, while the number of national cases diagnosed begins to increases In any event, the association of early containment measures combined with a generalized initial treatment for all positive cases, whatever their degree of severity, will have contributed to a reduction in the fatality rate of COVID 19 and a slowing down of its doubling time. CONCLUSIONS In Algeria, the rapid combination of rigorous containment measure at home and early generalized treatment with hydroxychloroquin have demonstrated their effectiveness in terms of morbidity and mortality, the classic measures of social distancing and hygiene will make it possible to perpetuate these results by reducing viral transmission, the only unknown, the reopening procedure which can only be started after being surrounded by precautions aimed at ensuring the understanding of the population. CLINICALTRIAL Algeria, Covid-19, pandemic, hydroxychloroquin, azithromycin, case fatality rate

Sign in / Sign up

Export Citation Format

Share Document